Seer, Inc. (SEER)
NASDAQ: SEER · IEX Real-Time Price · USD
2.110
-0.010 (-0.47%)
May 17, 2024, 4:00 PM EDT - Market closed
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $135.39 million as of May 17, 2024. Its market cap has decreased by -35.62% in one year.
Market Cap
135.39M
Enterprise Value
-146.00M
1-Year Change
-35.62%
Ranking
Category
Stock Price
$2.11
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $1.12B to $135.39M, a decrease of -87.89%. That is a compound annual growth rate of -45.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 137.00M | -0.51% |
| May 16, 2024 | 137.70M | -0.94% |
| May 15, 2024 | 139.00M | -0.93% |
| May 14, 2024 | 140.30M | 8.59% |
| May 13, 2024 | 129.20M | -0.23% |
| May 10, 2024 | 129.50M | -3.21% |
| May 9, 2024 | 133.80M | -7.60% |
| May 8, 2024 | 144.80M | 1.19% |
| May 7, 2024 | 143.10M | -1.38% |
| May 6, 2024 | 145.10M | - |
| May 3, 2024 | 145.10M | 3.72% |
| May 2, 2024 | 139.90M | 1.89% |
| May 1, 2024 | 137.30M | 1.93% |
| Apr 30, 2024 | 134.70M | 6.65% |
| Apr 29, 2024 | 126.30M | 2.10% |
| Apr 26, 2024 | 123.70M | 9.08% |
| Apr 25, 2024 | 113.40M | -1.05% |
| Apr 24, 2024 | 114.60M | -2.22% |
| Apr 23, 2024 | 117.20M | 8.32% |
| Apr 22, 2024 | 108.20M | 0.65% |
| Apr 19, 2024 | 107.50M | -5.20% |
| Apr 18, 2024 | 113.40M | 3.56% |
| Apr 17, 2024 | 109.50M | -3.44% |
| Apr 16, 2024 | 113.40M | -2.16% |
| Apr 15, 2024 | 115.90M | -2.77% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 145.07M |
| BioAtla | 144.32M |
| InfuSystem Holdings | 142.47M |
| American Well | 141.92M |
| I-Mab | 140.18M |
| Corvus Pharmaceuticals | 138.86M |
| Akoya Biosciences | 137.77M |
| TruBridge | 134.32M |